Potency of naltrexone to reduce ethanol self-administration in rats is greater for subcutaneous versus intraperitoneal injection
about
Drug effects on multiple and concurrent schedules of ethanol- and food-maintained behaviour: context-dependent selectivity.Low-dose prazosin alone and in combination with propranolol or naltrexone: effects on ethanol and sucrose seeking and self-administration in the P rat.Comparison of dehydroepiandrosterone (DHEA) and pregnanolone with existing pharmacotherapies for alcohol abuse on ethanol- and food-maintained responding in male rats.Inhibition of opioid transmission at the μ-opioid receptor prevents both food seeking and binge-like eatingPharmacological characterization of the 20% alcohol intermittent access model in Sardinian alcohol-preferring rats: a model of binge-like drinking.Opioid system in the medial prefrontal cortex mediates binge-like eatingOperant self-administration of alcohol and nicotine in a preclinical model of co-abusePreclinical evidence of new opioid modulators for the treatment of addiction.Neurochemical heterogeneity of rats predicted by different measures to be high ethanol consumers.Attenuation of cocaine and heroin seeking by μ-opioid receptor antagonismSupplier-dependent differences in intermittent voluntary alcohol intake and response to naltrexone in Wistar ratsCoadministration of intravenous nicotine and oral alcohol in ratsImproved effect of the combination naltrexone/D-penicillamine in the prevention of alcohol relapse-like drinking in rats.A Method for Evaluating the Reinforcing Properties of Ethanol in Rats without Water Deprivation, Saccharin Fading or Extended Access Training.Light alcohol intake during adolescence induces alcohol addiction in a neurodevelopmental model of schizophrenia.Effects of the nicotinic agonist varenicline, nicotinic antagonist r-bPiDI, and DAT inhibitor (R)-modafinil on co-use of ethanol and nicotine in female P rats.
P2860
Q33929790-558B1936-3476-42E2-A70F-4B6EB77BEBF5Q35858582-060B5EED-145C-471D-BADE-06A98A2DD9DBQ35887957-AA5A3AEF-337E-4C05-A448-5207AD863BEEQ36323534-20FAAC12-5B0C-4BEE-A385-37A7178CC9C2Q36594922-5BE7ABEA-4BCF-4B9B-9822-E0AAA9E51B64Q36876266-A40D1A78-2918-4BDA-A01A-0561DB91145AQ37709823-F03DD082-9F15-4D4B-8FAF-1F5ACA9AD2AFQ37772519-61B9AD42-B2E3-4F83-9D3F-775E15093A8AQ38714193-FA6AD6C0-20B2-4F96-AC5E-A4D78F12A52AQ39733620-4BE04654-E344-4A25-8214-B510DD5C7675Q42034211-60D155AA-E865-420D-B78D-E7F25C10C7A7Q42371322-03BDA9C7-A4CF-4D05-B88A-FA1F1F1A88E0Q46320227-A0849442-07BC-40F0-8A76-65E91CF8D21DQ47364757-8285240B-1DC7-474B-AB8A-4F28A4DA8760Q47780196-069A8A40-2D53-4C71-A7C0-BC23F0DCDDB7Q49892752-865C6AC0-964C-41B2-A72E-9FC11E74057E
P2860
Potency of naltrexone to reduce ethanol self-administration in rats is greater for subcutaneous versus intraperitoneal injection
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Potency of naltrexone to reduc ...... rsus intraperitoneal injection
@en
Potency of naltrexone to reduc ...... sus intraperitoneal injection.
@nl
type
label
Potency of naltrexone to reduc ...... rsus intraperitoneal injection
@en
Potency of naltrexone to reduc ...... sus intraperitoneal injection.
@nl
prefLabel
Potency of naltrexone to reduc ...... rsus intraperitoneal injection
@en
Potency of naltrexone to reduc ...... sus intraperitoneal injection.
@nl
P2860
P1433
P1476
Potency of naltrexone to reduc ...... rsus intraperitoneal injection
@en
P2093
Carissa L Broadbridge
P2860
P304
P356
10.1016/J.ALCOHOL.2008.11.003
P577
2009-03-01T00:00:00Z